These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 24475217)

  • 1. miR-342 regulates BRCA1 expression through modulation of ID4 in breast cancer.
    Crippa E; Lusa L; De Cecco L; Marchesi E; Calin GA; Radice P; Manoukian S; Peissel B; Daidone MG; Gariboldi M; Pierotti MA
    PLoS One; 2014; 9(1):e87039. PubMed ID: 24475217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumoral expression of BRCA1, estrogen receptor alpha and ID4 protein in patients with sporadic breast cancer.
    Roldán G; Delgado L; Musé IM
    Cancer Biol Ther; 2006 May; 5(5):505-10. PubMed ID: 16582598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Id4 protein is highly expressed in triple-negative breast carcinomas: possible implications for BRCA1 downregulation.
    Wen YH; Ho A; Patil S; Akram M; Catalano J; Eaton A; Norton L; Benezra R; Brogi E
    Breast Cancer Res Treat; 2012 Aug; 135(1):93-102. PubMed ID: 22538771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic regulation of ID4 in breast cancer: tumor suppressor or oncogene?
    Nasif D; Campoy E; Laurito S; Branham R; Urrutia G; Roqué M; Branham MT
    Clin Epigenetics; 2018 Aug; 10(1):111. PubMed ID: 30139383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased ID4 expression, accompanied by mutant p53 accumulation and loss of BRCA1/2 proteins in triple-negative breast cancer, adversely affects survival.
    Thike AA; Tan PH; Ikeda M; Iqbal J
    Histopathology; 2016 Apr; 68(5):702-12. PubMed ID: 26259780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Id4 messenger RNA and estrogen receptor expression: inverse correlation in human normal breast epithelium and carcinoma.
    de Candia P; Akram M; Benezra R; Brogi E
    Hum Pathol; 2006 Aug; 37(8):1032-41. PubMed ID: 16867866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-342 overexpression results in a synthetic lethal phenotype in BRCA1-mutant HCC1937 breast cancer cells.
    Crippa E; Folini M; Pennati M; Zaffaroni N; Pierotti MA; Gariboldi M
    Oncotarget; 2016 Apr; 7(14):18594-604. PubMed ID: 26919240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ERα-miR-575-p27 feedback loop regulates tamoxifen sensitivity in ER-positive Breast Cancer.
    Liu SS; Li Y; Zhang H; Zhang D; Zhang XB; Wang X; Yu Y
    Theranostics; 2020; 10(23):10729-10742. PubMed ID: 32929377
    [No Abstract]   [Full Text] [Related]  

  • 9. CDC42 as an epigenetic regulator of ID4 in triple-negative breast tumors.
    Nasif D; Real S; Roqué M; Branham MT
    Breast Cancer; 2022 May; 29(3):562-573. PubMed ID: 35094293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of miR-10b, miR-26a, miR-146a and miR-153 as potential triple-negative breast cancer biomarkers.
    Fkih M'hamed I; Privat M; Ponelle F; Penault-Llorca F; Kenani A; Bignon YJ
    Cell Oncol (Dordr); 2015 Dec; 38(6):433-42. PubMed ID: 26392359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and regulatory function of miRNA-182 in triple-negative breast cancer cells through its targeting of profilin 1.
    Liu H; Wang Y; Li X; Zhang YJ; Li J; Zheng YQ; Liu M; Song X; Li XR
    Tumour Biol; 2013 Jun; 34(3):1713-22. PubMed ID: 23430586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integration of BRCA1-mediated miRNA and mRNA profiles reveals microRNA regulation of TRAF2 and NFκB pathway.
    Tanic M; Zajac M; Gómez-López G; Benítez J; Martínez-Delgado B
    Breast Cancer Res Treat; 2012 Jul; 134(1):41-51. PubMed ID: 22167321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced RAD21 cohesin expression confers poor prognosis in BRCA2 and BRCAX, but not BRCA1 familial breast cancers.
    Yan M; Xu H; Waddell N; Shield-Artin K; Haviv I; ; McKay MJ; Fox SB
    Breast Cancer Res; 2012 Apr; 14(2):R69. PubMed ID: 22537934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ID4 controls luminal lineage commitment in normal mammary epithelium and inhibits BRCA1 function in basal-like breast cancer.
    Baker LA; Holliday H; Swarbrick A
    Endocr Relat Cancer; 2016 Sep; 23(9):R381-92. PubMed ID: 27412917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA deregulation in triple negative breast cancer reveals a role of miR-498 in regulating BRCA1 expression.
    Matamala N; Vargas MT; González-Cámpora R; Arias JI; Menéndez P; Andrés-León E; Yanowsky K; Llaneza-Folgueras A; Miñambres R; Martínez-Delgado B; Benítez J
    Oncotarget; 2016 Apr; 7(15):20068-79. PubMed ID: 26933805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of ID4 protein in breast cancer cells induces reprogramming of tumour-associated macrophages.
    Donzelli S; Milano E; Pruszko M; Sacconi A; Masciarelli S; Iosue I; Melucci E; Gallo E; Terrenato I; Mottolese M; Zylicz M; Zylicz A; Fazi F; Blandino G; Fontemaggi G
    Breast Cancer Res; 2018 Jun; 20(1):59. PubMed ID: 29921315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA cluster 221-222 and estrogen receptor alpha interactions in breast cancer.
    Di Leva G; Gasparini P; Piovan C; Ngankeu A; Garofalo M; Taccioli C; Iorio MV; Li M; Volinia S; Alder H; Nakamura T; Nuovo G; Liu Y; Nephew KP; Croce CM
    J Natl Cancer Inst; 2010 May; 102(10):706-21. PubMed ID: 20388878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the epigenetic profile of ID4 in breast cancer: bioinformatic insights into methylation patterns and chromatin accessibility dynamics.
    Nasif D; Laurito S; Real S; Branham MT
    Breast Cancer Res Treat; 2024 Aug; 207(1):91-101. PubMed ID: 38702584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypic analysis of familial breast cancer: comparison of BRCAx tumors with BRCA1-, BRCA2-carriers and non-familial breast cancer.
    Aloraifi F; Alshehhi M; McDevitt T; Cody N; Meany M; O'Doherty A; Quinn CM; Green AJ; Bracken A; Geraghty JG
    Eur J Surg Oncol; 2015 May; 41(5):641-6. PubMed ID: 25736863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miRNA expression patterns in normal breast tissue and invasive breast cancers of BRCA1 and BRCA2 germ-line mutation carriers.
    Vos S; Vesuna F; Raman V; van Diest PJ; van der Groep P
    Oncotarget; 2015 Oct; 6(31):32115-37. PubMed ID: 26378051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.